Neuroblastoma complex

Part of the Current Histopathology book series (CUHI, volume 22)


Neuroblastoma is the archetypal and most common variant of peripheral primitive neuroectodermal tumour1. The third commonest solid malignant tumour of infancy and childhood, it is surpassed only by neoplasms of the lymphoid tissue and cerebral tumours2.3. It constitutes some 8-10% of all cancers seen in patients up to the age of 15 years. Ninety per cent of neuroblastomas occur in patients less than 10 years old4. The usual age at presentation is between birth and 5 years and boys are slightly more often affected than girls.


Neuroblastic Tumor Pediatr Pathol Adrenal Neuroblastoma Undifferentiated Neuroblastoma Marrow Bone Marrow 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Dehner L.P. Peripheral and central primitive neuroectodermal tumors. A nosologic concept seeking a consensus. Arch Pathol Lab Med. 1986;110:997–1005.PubMedGoogle Scholar
  2. 2.
    Marsden H.B., Steward J.B. (eds). Tumours in children. Berlin, Heidelberg, New York: Springer; 1976:1.CrossRefGoogle Scholar
  3. 3.
    Young J.L., Miller R.W. Incidence of malignant tumors in children. J Pediatr. 1975;86:254–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Kinnier Wilson L.M. Neuroblastoma, its natural history and prognosis: a study of 487 cases. Br Med J. 1974;3:301–7.CrossRefGoogle Scholar
  5. 5.
    Seeger R.C., Siegal S.E., Sidell N. Neuroblastoma: clinical perspectives, monoclonal antibodies, and retinoic acid. Ann Intern Med. 1982;97:873–84PubMedGoogle Scholar
  6. 6.
    Adam A. Hocholzer L. Ganglioneuroblastoma of the posterior mediastinum: a clinicopathologic review of 80 cases. Cancer. 1981;47:373–81.PubMedCrossRefGoogle Scholar
  7. 7.
    Brown R.J., Szymula N.J., Lore J.M. Neuroblastoma of the head and neck. Arch Otolaryngol. 1978;104:395–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Punt J, Pritchard J, Pincott J.R. et al. Neuroblastoma: a review of 21 cases presenting with spinal cord compression. Cancer. 1980;45;3095–101.PubMedCrossRefGoogle Scholar
  9. 9.
    Beckwith J.B., Martin R.F. Observations on the histopathology of neuroblastoma. J Pediatr Surg. 1968;3:106–10.PubMedCrossRefGoogle Scholar
  10. 10.
    Brodeur G.M., Seeger R.C., Barrett A. et al. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol. 1988;6:1874–81.PubMedGoogle Scholar
  11. 11.
    Triche T.J., Askin F.B. Neuroblastoma and the differential diagnosis of small-, round-, blue-cell tumors. Hum Pathol. 1983;14:569–95.PubMedCrossRefGoogle Scholar
  12. 12.
    Shimada H, Chatten J, Newton W.A. et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and age-linked classification of neuroblastomas. J Natl Cancer Inst. 1984;73:405–13.PubMedGoogle Scholar
  13. 13.
    Tobin R., Grippo R.A. Pulmonary metastases in neuroblastoma. Am J R. 1982;138:75–8.Google Scholar
  14. 14.
    Mills A.E., Bird A.R. Bone marrow changes in neuroblastoma. Pediatr Pathol. 1986;5:225–34.PubMedCrossRefGoogle Scholar
  15. 15.
    Oppedal B.R., Storm-Mathison I. Kemshead J.T., Brandtzaeg P. Bone marrow examination in neuroblastoma patients. A morphologic, immunocytochemical and immunohistochemical study. Hum Pathol. 1989;20:800–5.PubMedCrossRefGoogle Scholar
  16. 16.
    Turkel S.B., Itabashi H.H. The natural history of neuroblastoma cells in the fetal adrenal gland. Am J Pathol. 1974;76:225–44.PubMedGoogle Scholar
  17. 17.
    Beckwith J.B., Perrin E.W. In situ neuroblastoma. Am J Pathol. 1963;43:1089–99.PubMedGoogle Scholar
  18. 18.
    Bolande R.P. Benignity of neonatal tumors and the concept of cancer repression in early life. Am J Dis Child. 1971;122:12–14.Google Scholar
  19. 19.
    Knudson A.G., Meadows A.T. Regression of neuroblastoma IV-S; a genetic hypothesis. N Engl J Med. 1980;302:1254–5.PubMedCrossRefGoogle Scholar
  20. 20.
    Stout A.P. Ganglioneuroma of the sympathetic nervous system. Surg Gynecol Obstet. 1947;84:101–9.PubMedGoogle Scholar
  21. 21.
    Schweisguth O. Excretion of catecholamine metabolites in the urine of neuroblastoma patients. J Pediatr Surg. 1968;3:118–20.PubMedCrossRefGoogle Scholar
  22. 22.
    Evans A.E. Staging and treatment of neuroblastoma. Cancer. 1980;45:1799–802.PubMedGoogle Scholar
  23. 23.
    Kogut M.D., Kaplan S.A. Systemic manifestations of neurogenic tumors. J Pediatr. 1962;60:694–704.PubMedCrossRefGoogle Scholar
  24. 24.
    Mendelsohn G., Eggleston J.C., Olson J.L. Said S.I. Baylin S.B. Vasoactive intestinal peptide and its relation to ganglion cell differentiation in neuroblastic tumors. Lab Invest. 1979;41:144–9.PubMedGoogle Scholar
  25. 25.
    Triche T.J. Neuroblastoma and other childhood neural tumors: a review. Pediatr Pathol. 1990;10:175–93.PubMedCrossRefGoogle Scholar
  26. 26.
    Carter R.L., Al-Sam S.Z., Corbett R.P., Clinton S. A comparative study of immunohistochemical staining for neuron-specific enolase, protein gene product 9.5 and S-100 protein in neuroblastoma. Ewing’s sarcoma and other round cell tumours in children. Histopathology. 1990;16:461–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Shimada H., Aoyama C., Chiba T., Newton W.A. Prognostic subgroups for undifferentiated neuroblastoma: immunohistochemical study with anti-S-100 protein antibody. Hum Pathol. 1985;16:471–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Misugi K., Misugi N., Newton W.A. Fine structural study of neuroblastoma, ganglioneuroblastoma and phaeochromocytoma. Arch Pathol Lab Med. 1968;86:160–9.Google Scholar
  29. 29.
    Yokoyama M., Okada K., Tolue A. Takayasu H., Yamada R. Ultrastructural and biochemical study of neuroblastoma and ganglioneuroblastoma. Invest Urol. 1971;9:156–63.PubMedGoogle Scholar
  30. 30.
    Taxy J.B. Electron microscopy in the diagnosis of neuroblastoma. Arch Pathol Lab Med. 1980;104:355–60.PubMedGoogle Scholar
  31. 31.
    Mackay B., Maasse S.R., King O.Y., Butler J.J. Diagnosis of neuroblastoma by electron microscopy of bone marrow aspirates. Pediatrics. 1975;56:1045–9.PubMedGoogle Scholar
  32. 32.
    Reynolds C.P., Smith R.G., Frenkel E.P. The diagnostic dilemma of the’ small round cell neoplasm’. Cancer. 1981;48:2088–94.PubMedCrossRefGoogle Scholar
  33. 33.
    Bill A.H.. The regression of neuroblastoma. J Pediatr Surg. 1968;3:103–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Oppedal B.R., Storm-Mathisen I. Lie S.O., Brandtzaeg P. Prognostic factors in neuroblastoma. Clinical. histopathological and immunohistochemical features and DNA ploidy in relation to prognosis.Cancer. 1988;62:772–80.PubMedCrossRefGoogle Scholar
  35. 35.
    D’Angio G.J., Evans A.E., Koop C.E. Special pattern of widespread neuroblastoma with a favourable prognosis. Lancet. 1971;1:1046–9.PubMedCrossRefGoogle Scholar
  36. 36.
    Wilson P.C.G., Coppes M.J., Solh H. et al. Neuroblastoma stage IV-S: a heterogeneous disease. Med Pediatr Oncol. 1991;19:467–72.PubMedCrossRefGoogle Scholar
  37. 37.
    Haas O, Ablin A.R., Miller C., Zoger S., Matthay K.K. Complete pathologic maturation and regression of stage IVS neuroblastoma without treatment. Cancer. 1988;62:818–25.PubMedCrossRefGoogle Scholar
  38. 38.
    Stephenson S.R., Cook B.A. Mease A.D., Ruymann F.B. The prognostic significance of age and pattern of metastases in Stage IV-S neuroblastoma. Cancer. 1986;58:372–5.PubMedCrossRefGoogle Scholar
  39. 39.
    Triche T.J. Round cell tumours in childhood: the application of newer techniques to the differential diagnosis. Perspect Pediatr Pathol. 1982;7:279–322.PubMedGoogle Scholar
  40. 40.
    Phillips W.S., Stafford P.W., Duvol-Arnold B., Ghosh B.C. Neuroblastoma and the clinical significance of N-myc oncogene amplification. Surg Gynecol Obstet. 1991;172:73–80.PubMedGoogle Scholar
  41. 41.
    Brodeur G.M., Hayes F.A. Green A.A. et al. Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients. Cancer Res. 1987;47:4248–53.PubMedGoogle Scholar
  42. 42.
    Seeger R.C., Brodeur G.M., Sather H et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastoma. N Engl J Med. 1985;313:1111–16.PubMedCrossRefGoogle Scholar
  43. 43.
    Hayashi Y., Kanda N., Inaba T. et al. Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer. 1989;63:126–32.PubMedCrossRefGoogle Scholar
  44. 44.
    Cohn S.L., Rademaker A.W., Salwen H.R. et al. Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma. Am J Pathol. 1990;136:1043–52.PubMedGoogle Scholar
  45. 45.
    Naito M., Iwafuchi M., Ohsawa Y. et al. Flow cytometric DNA analysis of neuroblastoma: prognostic significance of DNA ploidy in unfavourable group. J Pediatr Surg. 1991;26:834–7.PubMedCrossRefGoogle Scholar
  46. 46.
    Taylor S.R., Blatt J., Costantino J.P., Roederer M., Murphy R.F. Flow cytometric DNA analysis of neuroblastoma and ganglioneuroma. A 10-year retrospective study. Cancer. 1988;62:749–54.PubMedCrossRefGoogle Scholar
  47. 47.
    Fong C.T., Dracopoli N., White P.S. et al. Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastoma: correlation with N-myc amplification. Proc Natl Acad Sci USA. 1989;86:3753–7.PubMedCrossRefGoogle Scholar
  48. 48.
    Look A.T. Hayes A. Shuster J.J. et al. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a pediatric oncology group study. J Clin Oncol. 1991;9:581–91.PubMedGoogle Scholar

Copyright information

© S. Variend 1993

Authors and Affiliations

  1. 1.Department of HistopathologySheffield Children’s HospitalSheffieldUK

Personalised recommendations